Sentence examples for develop pharmaceuticals from inspiring English sources

Nonetheless, he said, once the basic science of migraine is better understood, it will be possible to develop pharmaceuticals that aim to prevent attacks without untoward side effects.

The crystal structure of the RNase A 3′-N-piperidine-4-carboxyl-3′-deoxy-ara-uridine complex provides evidence of A 3′-N-piperidine-4-carboxyl-3′-deoxy-ara-uridineN-A 3′-N-piperidine-4-carboxyl-3′-deoxy-ara-uridinelling studies, while it A 3′-N-piperidine-4-carboxyl-3′-deoxy-ara-uridineselectivity of such compounds to develop phA 3′-N-piperidine-4-carboxyl-3′-deoxy-ara-uridine RNA 3′-N-piperidine-4-carboxyl-3′-deoxy-ara-uridine

The study has provided information about the antioxidant activity of N. arbor tristis, which will be useful to develop pharmaceuticals for the treatment of arthritis.

The prevalent model (developed by drug companies to develop pharmaceuticals) just studies one chemical at a time.

It is clear now that PPARα can be activated in humans and that humans are at least as sensitive as laboratory animals for some effects, that is, those related to lipid regulation and that are the target of an extensive effort to develop pharmaceuticals using this mechanism.

As such, this enzyme is likely to provide a useful target when using a rational drug design approach to develop pharmaceutical reagents, including cancer therapeutics.

In China, where the pharmaceuticals industry is so afraid of IP theft, do you think conditions are satisfactory now, to be willing to consider partnership to develop pharmaceutical products?

This Nobel Laureate was determined to develop pharmaceutical drugs after watching her beloved grandfather die slowly and painfully from stomach cancer.

The overall theme of the two-day workshop was 'Medicines for Children' and the efforts to develop pharmaceutical products specifically for children.

This strongly supports the use of NRs as novel targets to develop pharmaceutical agents for the treatment of circadian clock-associated disorders such as metabolic syndromes.

In life, and especially in developing pharmaceuticals, shape matters.